Jorge L Iglesias

Jorge L Iglesias

UNVERIFIED PROFILE

Are you Jorge L Iglesias?   Register this Author

Register author
Jorge L Iglesias

Jorge L Iglesias

Publications by authors named "Jorge L Iglesias"

Are you Jorge L Iglesias?   Register this Author

2Publications

37Reads

20Profile Views

First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors.

Invest New Drugs 2015 Aug 8;33(4):901-10. Epub 2015 May 8.

Department of Medicine, University of Chicago, MC2115, 5841 South Maryland Avenue, Chicago, IL, 60637, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0247-1DOI Listing
August 2015